THE NF-κB AND IκB PROTEINS: New Discoveries and Insights

Article Properties
  • Language
    English
  • Publication Date
    1996/04/01
  • Indian UGC (Journal)
  • Refrences
    180
  • Citations
    4,575
  • Albert S. Baldwin Lineberger Comprehensive Cancer Center, Curriculum in Genetics and Molecular Biology, and Department of Biology, University of North Carolina, Chapel Hill, North Carolina 27599
Abstract
Cite
Baldwin, Albert S. “THE NF-κB AND IκB PROTEINS: New Discoveries and Insights”. Annual Review of Immunology, vol. 14, no. 1, 1996, pp. 649-81, https://doi.org/10.1146/annurev.immunol.14.1.649.
Baldwin, A. S. (1996). THE NF-κB AND IκB PROTEINS: New Discoveries and Insights. Annual Review of Immunology, 14(1), 649-681. https://doi.org/10.1146/annurev.immunol.14.1.649
Baldwin AS. THE NF-κB AND IκB PROTEINS: New Discoveries and Insights. Annual Review of Immunology. 1996;14(1):649-81.
Journal Categories
Medicine
Internal medicine
Specialties of internal medicine
Immunologic diseases
Allergy
Description

Delving into the complexities of inflammation and immunity! This review explores the intricate role of NF-κB, a transcription factor central to immune responses, inflammation, and cell growth. It focuses on its regulation by IκB proteins and the diverse stimuli that activate NF-κB, highlighting recent advances in understanding its mechanisms. The review examines how NF-κB activation is controlled by targeted phosphorylation and degradation of IκB, enabling NF-κB to enter the nucleus and activate gene transcription. It also discusses the discovery of multiple IκB forms, which appear to regulate NF-κB through different mechanisms, and recent structural and gene knockout studies that provide new insights into NF-κB function. Furthermore, the review examines the potential therapeutic targets. These discoveries hold promise for developing targeted therapies for diseases involving inappropriate NF-κB activation, such as inflammatory disorders and certain cancers. By elucidating the regulatory mechanisms governing NF-κB, this review contributes to the development of novel therapeutic strategies.

As a review in the Annual Review of Immunology, this article synthesizes current knowledge on NF-κB and IκB proteins, core components of the immune system. It aligns with the journal's focus on providing comprehensive and critical assessments of key topics in immunology, offering a valuable resource for researchers in the field.

Refrences
Citations
Citations Analysis
The first research to cite this article was titled Slow-binding inhibition of NAD+ glycohydrolase by arabino analogues of beta-NAD. and was published in 1992. The most recent citation comes from a 2024 study titled Slow-binding inhibition of NAD+ glycohydrolase by arabino analogues of beta-NAD. . This article reached its peak citation in 1999 , with 328 citations.It has been cited in 1,132 different journals, 18% of which are open access. Among related journals, the Journal of Biological Chemistry cited this research the most, with 372 citations. The chart below illustrates the annual citation trends for this article.
Citations used this article by year